09:41 AM EST - Migenix Inc. : said its fourth-quarter income and comprehensive income was $6.71 million or $0.05 per share compared with a loss of $3.24 million or $0.04 per share in the prior-year period. Fourth-quarter revenue decreased to $132,000 from $198,000 a year ago. Fiscal 2009 revenues were from work performed by MIGENIX personnel pursuant to: (1) the option agreement with United Therapeutics; and (2) a service agreement with Cadence Pharmaceuticals. Migenix Inc.
shares T.MGI are trading even at $0.04.
